Low Cost Wireless ECG Cardiac Monitor can Save Lives and Cut Healthcare Costs

Ultra low power (ULP) RF specialist Nordic Semiconductor ASA (OSE: NOD) today announces that British medical services startup, Isansys Lifecare Limited, has announced the world's first commercially-available, clinical-grade, wireless cardiac monitor to support low cost continuous ECG heart monitoring. This means cardiac patients can be monitored continuously and thus any problems detected when they are usually easier to treat, while avoiding life-threatening and costly emergency room-re-admissions.

By making the most costly elements of the Isansys LifeTouch HRV011 ECG wireless monitor recyclable, its application cost can fall (with repeated usage) to just a few tens of cents. In operation, the HRV011 resembles a lightweight bandage strip that adheres to a patient's body and analyses the ECG signal of every heartbeat in 4-5x more detail than that required for a wired ECG monitor. From this data, a proprietary algorithm running within an on-board ARM Cortex-based microcontroller is used to calculate key physiological parameters - including respiration rate and R-to-R peak intervals – to detect problems rapidly. Redundancy is also built-in because collected data is securely transmitted to a web-based HL7-compliant database.

The Nordic nRF24AP2's class-leading performance and use of the proven, ultra low power ANT wireless protocol help enable the LifeTouch HRV011 to achieve a battery operating life of up to 100 hours (four days) from a regular CR2032 coin cell battery under continuous usage conditions, while offering high interference immunity in even the most challenging (active Bluetooth and Wi-Fi) 2.4GHz RF operating environments.

"This product will mean that healthcare providers could save thousands of lives and slash millions of dollars from their over-stretched healthcare budgets," says Keith Errey, CEO at Isansys. "At present nearly one in three patients that are discharged from intensive care wards will suffer a relapse of some kind, often within a week or so of discharge. Our devices and services provide an early warning of adverse events, and thus allow earlier and generally less costly and traumatic interventions compared to an emergency re-admission into intensive care."

Errey continues: "Until now there has been no low cost solution to this problem. And given that in the U.S. many major medical insurers from next year are saying that will start treating many re-admissions as a failure on the part of the hospital and so not be liable for any further emergency room costs, our solution - which is commercially available now - could not be more timely."

"It's an unfortunate reality that aging populations and an explosion in lifestyle-related health problems such as obesity and linked conditions such as type-2 diabetes, are placing crippling financial burdens on government healthcare budgets, healthcare providers, and insurers," comments Geir Langeland, Nordic Semiconductor's Director of Sales & Marketing. "This situation is only going to worsen and is in desperate need of innovative technological solutions such as this low cost, wireless cardiac monitor from Isansys."

About Nordic Semiconductor
Nordic Semiconductor ('Nordic') is a fabless semiconductor company specializing in ultra low power (ULP) short-range wireless communication in the license-free 2.4GHz and sub-1-GHz Industrial, Scientific and Medical (ISM) bands. Nordic is a Norwegian public company listed on the Oslo stock exchange (OSE: NOD).

http://www.nordicsemi.com

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...